Clark Estates Inc. NY Takes Position in Teleflex Incorporated (NYSE:TFX)

Clark Estates Inc. NY acquired a new stake in Teleflex Incorporated (NYSE:TFX) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 15,000 shares of the medical technology company’s stock, valued at approximately $2,073,000.

Several other large investors have also made changes to their positions in the business. Headlands Technologies LLC purchased a new stake in Teleflex during the fourth quarter worth $29,000. Banque Cantonale Vaudoise purchased a new stake in Teleflex during the first quarter worth $27,000. MassMutual Private Wealth & Trust FSB boosted its holdings in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after buying an additional 100 shares in the last quarter. Whipplewood Advisors LLC boosted its holdings in Teleflex by 7,700.0% during the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock worth $32,000 after buying an additional 231 shares in the last quarter. Finally, Allworth Financial LP boosted its holdings in Teleflex by 504.8% during the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock worth $34,000 after buying an additional 212 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

TFX opened at $115.72 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. The company has a market cap of $5.11 billion, a price-to-earnings ratio of 36.50, a PEG ratio of 1.81 and a beta of 1.08. Teleflex Incorporated has a 52-week low of $108.90 and a 52-week high of $249.90. The firm’s fifty day simple moving average is $119.02 and its two-hundred day simple moving average is $138.17.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The company’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period last year, the firm posted $3.21 earnings per share. Equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend was Tuesday, May 20th. Teleflex’s dividend payout ratio is currently 42.90%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on TFX. Royal Bank Of Canada set a $130.00 price target on shares of Teleflex and gave the stock a “sector perform” rating in a report on Tuesday, July 15th. Wells Fargo & Company lowered their price target on shares of Teleflex from $146.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, May 2nd. Truist Financial lowered their price target on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a report on Monday, May 5th. Morgan Stanley lowered their price target on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a report on Monday, May 5th. Finally, Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Teleflex presently has an average rating of “Hold” and a consensus price target of $159.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.